The Rosen Law Firm Announces That It Has Filed a Securities Class Action to Recover Investors' Losses in Star Scientific, Inc. -

  The Rosen Law Firm Announces That It Has Filed a Securities Class Action to
  Recover Investors' Losses in Star Scientific, Inc. -- STSI

Business Wire

NEW YORK -- March 29, 2013

The Rosen Law Firm, P.A. today announced that it has filed a class action
lawsuit on behalf of investors who purchased common stock of Star Scientific,
Inc. ("STSI") (NASDAQ: STSI) from May 14, 2012, to January 22, 2013, seeking
remedies under the federal securities laws.

If you purchased stock before January 22, 2013 and wish to join the STSI class
action, please visit the firm's website at http://www.rosenlegal.com, or call
Jonathan Horne, Esq., toll-free, at 866-767-3653; you may also email
jhorne@rosenlegal.com for information on the class action. The case is pending
the U.S. District Court for the District of Massachusetts.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY
CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.

Throughout the course of 2012, STSI had been touting its relationship with
Johns Hopkins University, who was purportedly conducting studies relating to
STSI's product, Anatabloc. For example, a press release dated June 27, 2012
stated that research had been conducted by "[t]he independently funded
research team at Johns Hopkins [....]" In a Press Release dated January 7,
2013 announcing the results of STSI's clinical trials, STSI quoted Dr. Paul
Ladenson of Johns Hopkins University, but omitted mention of Johns Hopkins
University.

On January 23, 2013, TheStreet.com published an article refuting claims that
John’s Hopkins was conducting clinical trials with STSI. In the article, a
Johns Hopkins spokesperson is quoted as responding to Star Scientific's claim
that it was conducting a study with Johns Hopkins by stating: "We do have
guidelines about such things and he [Ladenson] is in violation here." The
Johns Hopkins spokesperson purportedly added that Johns Hopkins had started an
inquiry into the conduct. As a result of this adverse news, the price of STSI
stock fell on January 23, 2013, damaging investors. On March 18, 2013, Star
Scientific filed its 10-K for 2012, in which it announced that it and its
personnel had received subpoenas from the U.S. Attorney's Office.

If you wish to serve as lead plaintiff, you must move the Court no later than
May 24, 2013. A lead plaintiff is a representative party acting on behalf of
other class members in directing the litigation. If you wish to join the
litigation, or to discuss your rights or interests regarding this class
action, please contact Jonathan Horne, Esq. of The Rosen Law Firm, toll-free,
at 866-767-3653, or via e-mail at jhorne@rosenlegal.com. You may also visit
the firm's website at http://www.rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation.

Contact:

The Rosen Law Firm P.A.
Laurence M. Rosen, Esq.
Jonathan Horne, Esq.
275 Madison Avenue 34^th Floor
New York, New York 10016
Tel: (212) 686-1060
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
jhorne@rosenlegal.com
www.rosenlegal.com
 
Press spacebar to pause and continue. Press esc to stop.